Lyell Immunopharma Inc (LYEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LYEL | ZTS | TAK | UTHR | NBIX |
| Company | Lyell Immunopharma Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.4500 | 183.09 | 14.83 | 360.22 | 128.01 |
| High | 1.5000 | 184.22 | 14.93 | 364.45 | 129.68 |
| Low | 1.4200 | 180.98 | 14.80 | 359.29 | 123.84 |
| Last | 1.4500 | 183.49 | 14.89 | 363.55 | 127.06 |
| Change | -0.0100 | +0.60 | -0.06 | +3.33 | -1.37 |
| % Change | -0.68% | +0.33% | -0.40% | +0.92% | -1.07% |
| Volume | 1,025,500 | 2,328,500 | 1,859,500 | 464,800 | 1,236,800 |
| 20-Day Average Volume | 637,550 | 1,791,405 | 2,143,500 | 478,595 | 963,285 |
| Previous Close | 1.4600 | 182.89 | 14.95 | 360.22 | 128.43 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.4268 | 183.44 | 14.44 | 338.90 | 145.36 |
| 20-Day Raw Stochastic | 60.00% | 62.57% | 89.39% | 95.24% | 20.79% |
| 20-Day Relative Strength | 45.57% | 53.89% | 64.32% | 67.78% | 35.89% |
| Weighted Alpha | -54.08 | -0.79 | +2.06 | +75.06 | +5.72 |
| Today's Opinion | 88% Sell | 88% Buy | 64% Buy | 100% Buy | 8% Buy |
| Previous Opinion | 88% Sell | 72% Buy | 56% Buy | 100% Buy | 8% Buy |
| Last Month's Opinion | 88% Sell | 56% Buy | 8% Buy | 80% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.05% since 08/23/24 | +1.43% since 08/23/24 | -1.26% since 08/23/24 | +4.46% since 08/23/24 | -16.85% since 08/23/24 |
| Low | 1.4200 on 08/30/24 | 180.52 on 08/26/24 | 14.79 on 08/26/24 | 343.13 on 08/27/24 | 119.76 on 08/28/24 |
| High | 1.6050 on 08/26/24 | 184.71 on 08/29/24 | 15.06 on 08/28/24 | 365.98 on 08/28/24 | 154.00 on 08/26/24 |
| 1-Month | |||||
| %Chg | -8.23% since 07/30/24 | +0.91% since 07/30/24 | +9.08% since 07/30/24 | +7.71% since 07/30/24 | -10.00% since 07/30/24 |
| Low | 1.1950 on 08/14/24 | 172.24 on 08/05/24 | 13.29 on 08/06/24 | 310.00 on 07/31/24 | 119.76 on 08/28/24 |
| High | 1.6950 on 07/31/24 | 190.22 on 08/07/24 | 15.08 on 08/23/24 | 365.98 on 08/28/24 | 157.98 on 08/01/24 |
| 3-Month | |||||
| %Chg | -45.49% since 05/30/24 | +8.29% since 05/30/24 | +14.27% since 05/30/24 | +34.42% since 05/30/24 | -7.02% since 05/30/24 |
| Low | 1.1800 on 06/27/24 | 166.45 on 06/26/24 | 12.57 on 06/20/24 | 268.65 on 05/31/24 | 119.76 on 08/28/24 |
| High | 2.8000 on 06/03/24 | 190.22 on 08/07/24 | 15.08 on 08/23/24 | 365.98 on 08/28/24 | 157.98 on 08/01/24 |
| 6-Month | |||||
| %Chg | -50.34% since 02/29/24 | -7.48% since 02/29/24 | +2.06% since 02/29/24 | +61.12% since 02/29/24 | -2.56% since 02/29/24 |
| Low | 1.1800 on 06/27/24 | 144.80 on 04/22/24 | 12.57 on 06/20/24 | 221.53 on 04/01/24 | 119.76 on 08/28/24 |
| High | 3.2556 on 03/04/24 | 196.23 on 03/01/24 | 15.08 on 08/23/24 | 365.98 on 08/28/24 | 157.98 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 369,662 | 83,725,576 | 47,124,424 | 16,125,620 | 12,786,938 |
| Shares Outstanding, K | 254,939 | 456,295 | 3,164,837 | 44,356 | 100,637 |
| Annual Sales | 130,000 | 8,544,000,000 | 29,419,960,000 | 2,327,500,000 | 1,887,100,000 |
| Annual Net Income | -234,630,000 | 2,344,000,000 | 994,060,000 | 984,800,000 | 249,700,000 |
| Last Quarter Sales | 10,000 | 2,361,000,000 | 7,731,140,000 | 714,900,000 | 590,200,000 |
| Last Quarter Net Income | -45,810,000 | 624,000,000 | 609,590,000 | 278,100,000 | 65,000,000 |
| 60-Month Beta | -0.52 | 0.86 | 0.54 | 0.55 | 0.37 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 08/07/24 | 1.56 on 08/06/24 | 0.56 on 07/31/24 | 5.85 on 07/31/24 | 0.63 on 08/01/24 |
| Latest Earnings Date | 08/13/24 | 08/06/24 | 10/24/24 | 07/31/24 | 08/01/24 |
| Most Recent Dividend | N/A | 0.432 on 07/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 07/18/24 | 03/27/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 33.01 | 9.52 | 16.55 | 38.80 |